Metabolic disorders can lead to an abnormal accumulation or deficit of nutrient substances and intermediate metabolites, resulting in a number of devastating diseases and posing a grave threat to human health. GemPharmatech has established a series of metabolic disease models, including obesity, diabetes, hyperlipidemia, metabolic dysfunction-associated steatohepatitis, gout/hyperuricemia, and osteoporosis for the study of pathogenic pathways and related therapeutic drug development.
